Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.

Stratmann G, Russell IA, Merrick SH.

Ann Thorac Surg. 2003 Dec;76(6):2094-7.

PMID:
14667657
[PubMed - indexed for MEDLINE]
2.

The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.

Pychyńska-Pokorska M, Moll JJ, Krajewski W, Jarosik P.

Pediatr Crit Care Med. 2004 May;5(3):246-50.

PMID:
15115562
[PubMed - indexed for MEDLINE]
3.

Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.

DiDomenico RJ, Massad MG, Kpodonu J, Navarro RA, Geha AS.

Chest. 2005 May;127(5):1828-35. Review.

PMID:
15888865
[PubMed - indexed for MEDLINE]
4.

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

J Vasc Surg. 2011 Apr;53(4):1032-7. doi: 10.1016/j.jvs.2010.07.075. Epub 2011 Jan 7.

PMID:
21215579
[PubMed - indexed for MEDLINE]
Free Article
5.

Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.

Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.

Ann Thorac Surg. 2006 Nov;82(5):1779-83.

PMID:
17062247
[PubMed - indexed for MEDLINE]
6.

Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?

Yan Q, Chang AC.

Pediatr Crit Care Med. 2004 May;5(3):297-8. No abstract available.

PMID:
15167716
[PubMed - indexed for MEDLINE]
7.

Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding.

Vanek T, Straka Z, Hrabak J, Jares M, Brucek PJ, Votava J.

Jpn Heart J. 2004 Sep;45(5):855-60.

PMID:
15557726
[PubMed - indexed for MEDLINE]
Free Article
8.

Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.

Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD.

Pharmacotherapy. 2006 Apr;26(4):569-577.

PMID:
16553518
[PubMed - indexed for MEDLINE]
9.

Case 5-2006: recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection.

Faber P, Reid C, El-Shafei H, Falase B, DeAnda A Jr, Mazer CD.

J Cardiothorac Vasc Anesth. 2006 Oct;20(5):736-41. Epub 2006 Aug 24. No abstract available.

PMID:
17023299
[PubMed - indexed for MEDLINE]
10.

Use of recombinant activated factor VII after axillofemoral bypass grafting.

Cheng CA, Ho AM.

Anaesth Intensive Care. 2006 Jun;34(3):375-8.

PMID:
16802495
[PubMed - indexed for MEDLINE]
11.

Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".

Al-Ruzzeh S, Navia JL.

Circulation. 2010 Mar 9;121(9):e234. doi: 10.1161/CIR.0b013e3181d68ebc. No abstract available.

PMID:
20212289
[PubMed - indexed for MEDLINE]
Free Article
12.

Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?

Ballen J, Raabe M, Muirhead B.

Can J Anaesth. 2006 Apr;53(4):353-6.

PMID:
16575032
[PubMed - indexed for MEDLINE]
13.

Recombinant activated factor VII for treatment of refractory hemorrhage after surgery for acute aortic dissection.

Grubitzsch H, Vargas-Hein O, Von Heymann C, Konertz W.

J Cardiovasc Surg (Torino). 2009 Aug;50(4):531-4. Epub 2008 Oct 24.

PMID:
18948874
[PubMed - indexed for MEDLINE]
Free Article
14.

Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgery.

Kogler VM, Slobodnjak Z, Samarzija M, Macan JS, Karadza V, Jakopovic M.

Swiss Med Wkly. 2007 Jul 14;137(27-28):407-10.

PMID:
17705102
[PubMed - indexed for MEDLINE]
Free Article
15.

Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.

McCall P, Story DA, Karalapillai D.

Can J Anaesth. 2006 Sep;53(9):926-33. Erratum in: Can J Anaesth. 2006 Dec;53(12):1271. Karapillai, Darshi [corrected to Karalapillai, Darshi].

PMID:
16960271
[PubMed - indexed for MEDLINE]
16.

Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.

von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Grosse J, Ziemer S, Koscielny J, Konertz WF, Wernecke KD, Spies C.

Crit Care Med. 2005 Oct;33(10):2241-6.

PMID:
16215377
[PubMed - indexed for MEDLINE]
17.

Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Manning BJ, Hynes N, Courtney DF, Sultan S.

Eur J Vasc Endovasc Surg. 2005 Nov;30(5):525-7.

PMID:
16099693
[PubMed - indexed for MEDLINE]
Free Article
18.

Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.

Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.

Paediatr Anaesth. 2005 Mar;15(3):235-40.

PMID:
15725322
[PubMed - indexed for MEDLINE]
19.

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

J Intensive Care Med. 2004 Sep-Oct;19(5):270-3.

PMID:
15358945
[PubMed - indexed for MEDLINE]
20.

Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass.

Naik VN, Mazer CD, Latter DA, Teitel JM, Hare GM.

Can J Anaesth. 2003 Jun-Jul;50(6):599-602.

PMID:
12826554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk